The Bergen Gynecologic Cancer Research Group is affiliated with Department of Clinical Science (University of Bergen) and the Women's Clinic (Haukeland University Hospital).
We focus on clinical and translational research, with a special interest in endometrial and cervical cancer.
The group is headed by Professor Camilla Krakstad.
The Bergen Gynecologic Cancer Research Group is a multidisciplinary group aiming to improve treatment for women with gynecologic cancers. We have contributed with several important breakthroughs on molecular profiling of, in particular, endometrial and cervical cancer.
We have identified several potent biomarkers which could improve selection of patients for more individualized treatment. Our recent efforts also include developing advanced 3D cellular model systems. These models are important tools to perform functional studies and to evaluate how different genetic types of tumors respond to specific drugs.
Our group receives funding from the Reasearch Council of Norway, Norwegian Cancer Society, the Western Norway Regional Health Authority, UoB and Bergen Research Foundation.
